BEIJING,March 13,2025 -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital"),an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China,announced that it plans to release its unaudited financial results for the fourth quarter and full year ended December 31,2024 before U.S. market opens on Thursday,March 20,2025.
Yiren Digital's managementwill host an earnings conference call at 8:00 a.m. U.S. Eastern Time on March20,2025(or 8:00 p.m. Beijing/Hong Kong Time on March20,2025).
Participants who wish to join the call should register online in advance of the conference at: https://dpregister.com/sreg/10197602/feaaa46216
Once registration is completed,participants will receive the dial-in details for the conference call.
Additionally,a live and archived webcast of the conference call will be available at https://event.choruscall.com/mediaframe/webcast.html?webcastid=NaB0pL6P
About Yiren Digital
Yiren Digital Ltd. is an advanced,AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Our mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services,tailor-made insurance solutions,and premium lifestyle services. We support clients at various growth stages,addressing financing needs arising from consumption and production activities,while aiming to augment the overall well-being and security of individuals,families,and businesses.
HONG KONG,March 18,2025-- China Merchants Commercial Real Estate Investment Trust ("CMC REIT" or "the Trust",HKEX stock code:1503),announced its annual results for the year ended 3
Mar 18, 2025
XI\'AN,China,March 18,2025-- From March 11th to 13th,the largest photovoltaic exhibition in the Netherlands,Solar Solutions Amsterdam (SSA),was grandly held in Amsterdam. As a globally leading solar
Mar 18, 2025
Mar 10, 2025
MANILA,Philippines,March 3,2025-- In response to the growing demand for high-quality health supplements in the Philippines,Sole Pharma,as one of the leading European pharmaceutical manufacturer,announ
Mar 5, 2025